Premier Biomedical, Inc. (BIEI)

Market Cap	929.44K -10.6%
Revenue (ttm)	14.28K -64.1%
Net Income	-374.47K
EPS	-0.01
Shares Out	1.69B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,141,655
Open	0.0006
Previous Close	0.0006
Day's Range	0.0006 - 0.0007
52-Week Range	0.0003 - 0.0020
Beta	1.37
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Premier Biomedical

Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products comprising pain relief patch of hemp oil extracts; water-based and oil-based roll-on applicators; oil-based pump spray applicators; and ointments through its Website painreliefmeds.com and various distributors. It is also developing hemp oil products, including anti-pain patch, roll-on topical products, sprays, ointments, tincture drop product, a hemp oil ca...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2010
• Employees: 4
• Stock Exchange: OTCMKTS
• Ticker Symbol: BIEI

Financial Performance

In 2019, Premier Biomedical's revenue was $14,281, a decrease of -64.11% compared to the previous year's $39,795. Losses were -$374,470, -6.12% less than in 2018.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 5, 2026

Data Sources Report a data error